[Clinical study of a new drug in the treatment of diseases of the oral mucosa and periodontium].
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000942:Antigens, Bacterial; D000946:Antigens, Fungal; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D005035:Ethylmercury Compounds / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009059:Mouth Diseases / Q000188:drug therapy; D009061:Mouth Mucosa; D010510:Periodontal Diseases / Q000188:drug therapy*; D013849:Thimerosal / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D000942:Antigens, Bacterial; D000946:Antigens, Fungal; D004338:Drug Combinations; D005035:Ethylmercury Compounds; D013849:Thimerosal
Etude clinique d'un nouveau médicament dans le traitement des affections de la muqueuse buccale et du parodonte.